Comparison between "short" and "long" protocols in an ICSI programme

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 120, Issue 1, 2005, Pages 69-72

  Loutradis, D ^a   Stefanidis, K ^a,b   Drakakis, P ^a   El Sheikh, A ^a   Milingos, S ^a   Antsaklis, A ^a   Michalas, S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

ICSI programme; Long protocol; Ovarian stimulation; Short protocol

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; OOCYTE TRANSPORT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 18144390173     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.09.010     Document Type: Article

References (21)

1. E.G. Hughes, D.M. Federkow, S. Dayas, M.A. Sagle, P. Van de Koppel, and S.A. Collins The routine use of gonadotropin-releasing hormone agonist prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials Fertil Steril 58 1992 888 896
2. D. Loutradis, P. Drakakis, K. Kallianidis, S. Milingos, S. Dendrinos, and S. Michalas Oocyte morphology correlates with embryo quality and pregnancy rate after intracytoplasmic sperm injection Fertil Steril 72 1999 240 244
3. U. Acharya, J. Small, J. Randall, M. Hamilton, and A.I. Templeton Prospective study of short and long regimens of gonadotropin releasing hormone agonist in in vitro fertilization program Fertil Steril 57 1992 815 818
4. U. Acharya, S. Irvine, M. Hamilton, and A. Templeton Prospective study of short and ultrashort regiments of gonadotropin-releasing hormone agonist in an in vitro fertilization program Fertil Steril 58 1992 1169 1173
5. P. Bamere, P. Lopes, and J.P. Boiffard Use of GnRH analogues in ovulation induction for in vitro fertilization: benefit of a short administration regimen (letter) J In Vitro Fert Embryo Transf 4 1987 64 65
6. J.E. Garcia, S.L. Padilla, J. Bayati, and Baramki TA Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization Fertil Steril 53 1990 302 305
7. A. Hazout, A.de. Ziegler, C. Comel, N. Fernandez, C. Lelaidier, and R. Frydman Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation Fertil Steril 59 1993 596 600
8. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev 2000;2:CD001299.
9. S.L. Tan, C. Kingsland, and S. Campbell The long protocol of administration of gonadotropin releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization Fertil Steril 57 1992 810 814
10. B.C. Tarlatzis, G. Pados, and J. Bontis Ovarian stimulation with buserelin IHMG/HCG: prospective randomized study of short versus long protocol Hum Reprod 8 1993 807 812
11. D. Loutradis, P. Drakakis, and K. Kallianidis The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic infection Eur J Obstet Gynecol Reprod Biol 80 1998 251 255
12. D. Loutradis, K. Stefanidis, P. Drakakis, K. Kallianidis, G. Kallipolitis, and A. Elsheih Does the addition of menopausal gonadotropin to recombinant FSH in pituitary suppressed women improve clinical pregnancy in an intracytoplasmic sperm injection program? MEFSJ 8 2003 30 35
13. C. Kingsland, S.L. Tan, N. Bickerton, B. Mason, and S. Campbell The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization Is there any medical advantage? A prospective randomized study Fertil Steril 57 1992 804 809
14. D.R. Meldrum, A. Wisot, P. Hamilton, A.L. Gutlay, W.F. Kempton, and D. Huynk Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval Fertil Steril 51 1989 455 459
15. J. Smitz, R. Ron-El, and B.C. Tarlatzis The use of gonadotropin-releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centers Hum Reprod 7 1992 49 66
16. R. Ron-El, A. Herman, A. Golan, N. Nachum, and E. Caspi Gonadotropins and combined gonadotropin-releasing hormone agonist gonadotropins protocols in a randomized prospective study Fertil Steril 55 1991 574 578
17. R.G. Brzyski, S.J. Muasher, K. Droesch, S. Simonetti, G.S. Jones, and Z. Rosenwaks Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle stimulating hormone for oocyte recruitment Fertil Steril 50 1988 917 921
18. W.F. Crowley Jr., I.Z. Beitins, and W. Vale The biologic activity of a potent analogue of gonadotropin releasing hormone in normal and hypogonadotropic men N Engl J Med 302 1980 1052 1057
19. E. Loumaye, L. Vankrieken, S. Depreester, I. Psalti, S.de. Cooman, and K. Thomas Hormonal changes induced by short term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development Fertil Steril 51 1989 105 111
20. G.D. Palermo, M. Alikani, and M. Bertoli Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intracytoplasmic sperm injection Hum Reprod 11 1996 172 176
21. E. Tavmergen, E.N. Göker, F. Sendag, H. Sendag, and R. Levi Comparison of short and long ovulation induction protocols used in ART applications according to the ovarian response and outcome of pregnancy Arch Gynecol Obstet 266 2002 5 11